Lexicon Pharmaceuticals has reported that LX4211, an inhibitor of the sodium-dependent glucose transporter 2 (SGLT2; also known ... increase fluid excretion by a mechanism that depends on osmotic ...

The dual SGLT1/2 inhibitor sotagliflozin ... has not been observed in trials of selective SGLT2 inhibitors." "These results ...